Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Soto De Leon, Sara ^a,b   Camargo, Milena ^a,b   Sanchez, Ricardo ^a,c   Munoz, Marina ^a,b   Perez Prados, Antonio ^d   Purroy, Antonio ^d   Patarroyo, Manuel Elkin ^a,c   Patarroyo, Manuel Alfonso ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BINOMIAL DISTRIBUTION; COLOMBIA; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE AMPLIFICATION; GEOGRAPHIC DISTRIBUTION; HISPANIC; HUMAN; INDIGENOUS PEOPLE; INFECTION RATE; MAJOR CLINICAL STUDY; MIXED INFECTION; MULTIPARA; NEGRO; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; RNA VIRUS INFECTION; SEXUAL BEHAVIOR; SOCIAL STATUS; UTERINE CERVIX CANCER; WART VIRUS;

ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLOMBIA; DNA, VIRAL; FEMALE; GENETIC TESTING; GEOGRAPHY; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SOUTH AMERICA; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 79951906174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014705     Document Type: Article

References (60)

1. Villa LL, (1997) Human papillomaviruses and cervical cancer. Adv Cancer Res 71: 321-341.
2. Franco EL, Schlecht NF, Saslow D, (2003) The epidemiology of cervical cancer. Cancer J 9: 348-359.
3. WHO (2007) HPV and cervical cancer in the 2007 report. Vaccine 25(Suppl 3): C1-230.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
5. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H, (2004) Classification of papillomaviruses. Virology 324: 17-27.
6. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, et al. (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157: 218-226.
7. Koutsky L, (1997) Epidemiology of genital human papillomavirus infection. Am J Med 102: 3-8.
8. Winer RL, Kiviat NB, Hughes JP, Adam DE, Lee SK, et al. (2005) Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 191: 731-738.
9. Gauthier A, Martin-Escudero V, Moore L, Ferko N, de Sanjose S, et al. (2008) Long-term clinical impact of introducing a human papillomavirus 16/18 AS04adjuvant cervical cancer vaccine in Spain. Eur J Public Health 18: 674-680.
10. Rousseau MC, Abrahamowicz M, Villa LL, Costa MC, Rohan TE, et al. (2003) Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev 12: 1029-1037.
11. Mejlhede N, Bonde J, Fomsgaard A, (2009) High frequency of multiple HPV types in cervical specimens from Danish women. Apmis 117: 108-114.
12. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, et al. (1999) Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 180: 1415-1423.
13. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, et al. (2002) Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 87: 324-333.
14. Soto-De Leon SC, Camargo M, Sanchez R, Leon S, Urquiza M, et al. (2009) Prevalence of infection with high-risk human papillomavirus in women in Colombia. Clin Microbiol Infect 15: 100-102.
15. Moscicki AB, (2005) Impact of HPV infection in adolescent populations. J Adolesc Health 37: S3-9.
16. Baseman JG, Koutsky LA, (2005) The epidemiology of human papillomavirus infections. J Clin Virol 32(Suppl 1): S16-24.
17. Castellsague X, Bosch FX, Munoz N, (2002) Environmental co-factors in HPV carcinogenesis. Virus Res 89: 191-199.
18. Almonte M, Albero G, Molano M, Carcamo C, Garcia PJ, et al. (2008) Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 26(Suppl 11): L16-36.
19. Bello BD, Spinillo A, Alberizzi P, Cesari S, Gardella B, et al. (2009) Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol 81: 703-712.
20. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, et al. (2008) Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26(Suppl 10): K1-16.
21. Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, et al. (2001) Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 184: 1508-1517.
22. Herrero R, Hildesheim A, Rodriguez AC, Wacholder S, Bratti C, et al. (2008) Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine 26: 4795-4808.
23. Tabora N, Bakkers JM, Quint WG, Massuger LF, Matute JA, et al. (2009) Human papillomavirus infection in Honduran women with normal cytology. Cancer Causes Control 20: 1663-1670.
24. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, et al. (1996) Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 34: 2095-2100.
25. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, et al. (1997) PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35: 1304-1310.
26. Chang DY, Chen RJ, Lee SC, Huang SC, (1997) Prevalence of single and multiple infection with human papillomaviruses in various grades of cervical neoplasia. J Med Microbiol 46: 54-60.
27. McLaughlin-Drubin ME, Wilson S, Mullikin B, Suzich J, Meyers C, (2003) Human papillomavirus type 45 propagation, infection, and neutralization. Virology 312: 1-7.
28. Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, et al. (2004) Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol 78: 11172-11186.
29. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, et al. (2004) Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 57: 68-72.
30. Pista A, Oliveira A, Verdasca N, Ribeiro F, (2010) Single and multiple HPV infections in cervical abnormalities in Portuguese women. Clin Microbiol Infect In Press.
31. Mejlhede N, Pedersen BV, Frisch M, Fomsgaard A, (2010) Multiple human papilloma virus types in cervical infections: competition or synergy? Apmis 118: 346-352.
32. Depuydt CE, Boulet GA, Horvath CA, Benoy IH, Vereecken AJ, et al. (2007) Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 11: 881-891.
33. Tate JE, Yang YC, Shen J, McLachlin CM, Sheets EE, et al. (1996) A comparison of early (E7) and late (L1) primer-mediated amplification of papillomaviral DNA in cervical neoplasia. Mol Cell Probes 10: 347-351.
34. Chaturvedi AK, Myers L, Hammons AF, Clark RA, Dunlap K, et al. (2005) Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomarkers Prev 14: 2439-2445.
35. Napoles-Springer A, Perez-Stable EJ, Washington E, (1996) Risk factors for invasive cervical cancer in Latino women. J Med Syst 20: 277-293.
36. Kenney JW, (1996) Ethnic differences in risk factors associated with genital human papillomavirus infections. J Adv Nurs 23: 1221-1227.
37. Tonon SA, Picconi MA, Zinovich JB, Nardari W, Mampaey M, et al. (2004) Human papillomavirus cervical infection in Guarani Indians from the rainforest of Misiones, Argentina. International Journal of Infectious Diseases 8: 13-19.
38. Tortolero-Luna G, Mitchell MF, Swan DC, Tucker RA, Wideroff L, et al. (1998) A case-control study of human papillomavirus and cervical squamous intraepithelial lesions (SIL) in Harris County, Texas: differences among racial/ethnic groups. Cad Saude Publica 14(Suppl 3): 149-159.
39. Javanbakht M, Gorbach PM, Amani B, Walker S, Cranston RD, et al. (2010) Concurrency, sex partner risk, and high-risk human papillomavirus infection among African American, Asian, and Hispanic women. Sex Transm Dis 37: 68-74.
40. Ragin CC, Watt A, Markovic N, Bunker CH, Edwards RP, et al. (2009) Comparisons of high-risk cervical HPV infections in Caribbean and US populations. Infect Agent Cancer 4(Suppl 1): S9.
41. Gregoire L, Lawrence WD, Kukuruga D, Eisenbrey AB, Lancaster WD, (1994) Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer 57: 504-507.
42. Madeleine MM, Johnson LG, Smith AG, Hansen JA, Nisperos BB, et al. (2008) Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res 68: 3532-3539.
43. Mahmud SM, Robinson K, Richardson H, Tellier PP, Ferenczy AS, et al. (2007) HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students. J Infect Dis 196: 82-90.
44. Au WW, (2004) Life style, environmental and genetic susceptibility to cervical cancer. Toxicology 198: 117-120.
45. Dao DD, Sierra-Torres CH, Robazetti SC, de Gomez MN, Konig R, et al. (2005) HLA-DQB1 and cervical cancer in Venezuelan women. Gynecol Oncol 96: 349-354.
46. Goncalves MA, Le Discorde M, Simoes RT, Rabreau M, Soares EG, et al. (2008) Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 141: 70-74.
47. de Araujo Souza PS, Villa LL, (2003) Genetic susceptibility to infection with human papillomavirus and development of cervical cancer in women in Brazil. Mutat Res 544: 375-383.
48. Camargo M, Soto-DeLeon SC, Sanchez R, Perez-Prados A, Patarroyo ME, et al. (2010) Frequency of human papillomavirus infection, coinfection and association with different risk factors in Colombia. Annals of Epidemiology In Press.
49. Cervantes J, Lema C, Hurtado L, Andrade R, Quiroga G, et al. (2003) Prevalence of human papillomavirus infection in rural villages of the Bolivian Amazon. Rev Inst Med Trop Sao Paulo 45: 131-135.
50. Nelson JH, Hawkins GA, Edlund K, Evander M, Kjellberg L, et al. (2000) A novel and rapid PCR-based method for genotyping human papillomaviruses in clinical samples. J Clin Microbiol 38: 688-695.
51. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ, (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76 (Pt 4): 1057-1062.
52. Fuessel Haws AL, He Q, Rady PL, Zhang L, Grady J, et al. (2004) Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples. J Virol Methods 122: 87-93.
53. Iftner T, Villa LL, (2003) Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr pp. 80-88.
54. Remmerbach TW, Brinckmann UG, Hemprich A, Chekol M, Kuhndel K, et al. (2004) PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol 30: 302-308.
55. Lee YM, Leu SY, Chiang H, Fung CP, Liu WT, (2001) Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect 34: 87-91.
56. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, et al. (2004) Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol 42: 3176-3184.
57. Parkin DM, Louie KS, Clifford G, (2008) Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region. Vaccine 26(Suppl 12): M1-16.
58. Orjuela K, Amador C, Patarroyo MA, (2007) Synthetic genes: a tool for identifying human papillomavirus genotypes by hybridization and polymerase chain reaction-based assays. Diagn Microbiol Infect Dis 59: 101-104.
59. Kim H, Kriebel D, (2009) Regression models for public health surveillance data: a simulation study. Occup Environ Med 66: 733-739.
60. Barros AJ, Hirakata VN, (2003) Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3: 21.